Meeder Asset Management Inc Iovance Biotherapeutics, Inc. Transaction History

Meeder Asset Management Inc

$1.48 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$7.59 - $17.47 $667 - $1,537	88 New	88 $1,000
Q2 2022 Aug 08, 2022	SELL	$6.38 - $18.33 $6,781 - $19,484	-1,063 Reduced 98.7%	14 $0
Q1 2022 May 10, 2022	BUY	$12.38 - $19.1 $13,333 - $20,570	1,077 New	1,077 $18,000
Q2 2021 Aug 09, 2021	SELL	$16.33 - $33.07 $226,676 - $459,044	-13,881 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$28.67 - $52.59 $397,968 - $730,001	13,881 New	13,881 $439,000
Q4 2020 Feb 09, 2021	SELL	$28.04 - $50.26 $176,315 - $316,034	-6,288 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$27.75 - $36.3 $48,312 - $63,198	-1,741 Reduced 21.68%	6,288 $207,000
Q2 2020 Aug 11, 2020	BUY	$27.21 - $41.0 $51,154 - $77,080	1,880 Added 30.57%	8,029 $220,000
Q1 2020 May 15, 2020	SELL	$19.54 - $38.85 $36,832 - $73,232	-1,885 Reduced 23.46%	6,149 $185,000
Q4 2019 Feb 13, 2020	BUY	$17.95 - $29.41 $30,120 - $49,349	1,678 Added 26.4%	8,034 $223,000
Q3 2019 Oct 17, 2019	BUY	$17.99 - $26.0 $93,673 - $135,382	5,207 Added 453.18%	6,356 $116,000
Q2 2019 Aug 05, 2019	BUY	$9.78 - $24.52 $1,936 - $4,854	198 Added 20.82%	1,149 $29,000
Q1 2019 Apr 16, 2019	SELL	$8.41 - $11.26 $832 - $1,114	-99 Reduced 9.43%	951 $9,000
Q4 2018 Jan 17, 2019	BUY	$7.51 - $11.93 $5,302 - $8,422	706 Added 205.23%	1,050 $9,000
Q3 2018 Nov 02, 2018	SELL	$11.25 - $17.7 $12,015 - $18,903	-1,068 Reduced 75.64%	344 $0
Q2 2018 Jul 24, 2018	SELL	$12.45 - $16.95 $2,589 - $3,525	-208 Reduced 12.84%	1,412 $0
Q1 2018 May 03, 2018	BUY	$8.1 - $19.5 $4,155 - $10,003	513 Added 46.34%	1,620 $28,000
Q4 2017 Feb 02, 2018	BUY	$6.65 - $9.25 $5,792 - $8,056	871 Added 369.07%	1,107 $9,000
Q3 2017 Oct 20, 2017	BUY	$4.45 - $8.55 $1,050 - $2,017	236	236 $2,000

Others Institutions Holding IOVA

# of Institutions

314

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.24B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account